author-photo

Ovidio Fernandez Calvo

41

Papers

108

Citations

Citation Trend

Filter By

Papers (26) Sort By

Journal Conference Others

The role of systemic inflammatory factors in gastroenteropancreatic neuroendocrine tumors (GEP-NETs) treated with peptide receptor radionuclide therapy (PRRT).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Real-world efficacy and safety of peptide receptor radionuclide therapy (PRRT) in gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
In geriatric evaluation, some iadl (Katz) scale items are more predictive of efficacy and toxicity than ADL (Lawton) scale or Charlson Comorbidity Index in metastasic castration-resistant protate cancer (mCRPC) patients treated with cabazitaxel in a weekly schedule.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Delphi Consensus on the Follow-up of Cancer Patients with Breakthrough Pain Under Opioid Treatment

2019
Show All
- Source
- Cite
- Save
Citations (0)
Delphi consensus on the follow-up of cancer patients with breakthrough pain under opioid treatment.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A phase II multicenter biomarker trial to study the predictive value of TMPRSS2-ERG before enzalutamide treatment in chemo-naïve metastatic castration-resistant prostate cancer.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Epidemiología y factores pronósticos de los tumores neuroendocrinos

2018
Show All
- Source
- Cite
- Save
Citations (0)
Neuroendocrine Pulmonary Tumors of Low, Intermediate and High Grade: Anatomopathological Diagnosis—Prognostic and Predictive Factors

2018 Molecular Diagnosis & Therapy
Show All
- Source
- Cite
- Save
Citations (2)
Association of CTC detection by AdnaTest with outcome on enzalutamide in chemotherapy-naïve castration-resistant prostate cancer: Exploratory results from PREMIERE—A SOGUG trial.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Vinflunine (VFL) as second-line chemotherapy for patients with transitional cell carcinoma of the urothelium (TCCU): A multicenter retrospective study.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)